Last reviewed · How we verify
Resveratrol Pill
Resveratrol is a polyphenolic compound that activates sirtuins and other cellular stress-response pathways to promote antioxidant and anti-inflammatory effects.
Resveratrol is a polyphenolic compound that activates sirtuins and other cellular stress-response pathways to promote antioxidant and anti-inflammatory effects. Used for Cardiovascular health support, Metabolic and anti-aging applications.
At a glance
| Generic name | Resveratrol Pill |
|---|---|
| Sponsor | Russian Academy of Medical Sciences |
| Drug class | Natural polyphenol / Sirtuin activator |
| Target | SIRT1, antioxidant pathways, NF-κB |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular, Metabolic health, Anti-aging |
| Phase | FDA-approved |
Mechanism of action
Resveratrol is a natural polyphenol found in grapes and red wine that acts as a sirtuin activator, particularly SIRT1, which regulates cellular metabolism and stress responses. It also functions as an antioxidant and anti-inflammatory agent by scavenging free radicals and modulating NF-κB signaling. These mechanisms are proposed to support cardiovascular health, metabolic function, and cellular longevity.
Approved indications
- Cardiovascular health support
- Metabolic and anti-aging applications
Common side effects
- Gastrointestinal upset
- Headache
- Nausea
Key clinical trials
- Strength Training and Resveratrol (NA)
- Nicotinamide Riboside With and Without Resveratrol to Improve Functioning in Peripheral Artery Disease (PHASE3)
- Resveratrol and Vascular Function in CKD (NA)
- Use of Resveratrol to Decrease Acute Secondary Brain Injury Following Sports-Related Concussions in Boxers (PHASE1, PHASE2)
- Efficacy of Resveratrol in Depression (PHASE4)
- Effect of Resveratrol on Metabolic Parameters and Oocyte Quality in PCOS Patients (NA)
- Long-term Resveratrol and Metabolism (NA)
- Cardiovascular Health of Older Adults and Resveratrol (CORE)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Resveratrol Pill CI brief — competitive landscape report
- Resveratrol Pill updates RSS · CI watch RSS
- Russian Academy of Medical Sciences portfolio CI